← Open Payments lookup

JOLEEN LESZCZYNSKI: Open Payments

NPI 1508538778 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,482 in 70 payments from 11 companies in 2025. Trend: 2023 $1,974 · 2024 $1,977 · 2025 $1,482

Food & beverage: $1,482
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP26$625
GlaxoSmithKline, LLC.15$238
Grifols USA, LLC9$173
Viatris Specialty LLC7$160
Boehringer Ingelheim Pharmaceuticals, Inc.4$93
Verona Pharma, Inc.2$50
Regeneron Healthcare Solutions, Inc.2$44
GENZYME CORPORATION2$32
Takeda Pharmaceuticals U.S.A., Inc.1$24
Baxter Healthcare1$23

Products named: FASENRA, BREZTRI, Prolastin-C Liquid, YUPELRI, NUCALA, AIRSUPRA, TRELEGY ELLIPTA, DUPIXENT.

Industry payments across NM — which companies pay providers there.